Study explains the path a drug takes from its creation in a laboratory to a pharmacy.
When the new medicine has been created in the lab, it has to pass various strictly supervised tests before it will be available to society. Only following verification that it is possible to be a good medicine by showing its strengths in preclinical trials, can it be thought of as being usable for human trials.
If a medication has illustrated positive results in animal trials, it then has to be submitted to the IND (Investigational New Drug) along with the FDA (Federal Drug Administration) before it is permitted for use in human trials. The drug will be usable on human subjects upon determination of its toxicity levels and upon satisfaction that the drug has potential benefits.
The clinical trials’ Phase 1 is involved with studying the safety as well as toxicity levels of the new drug on volunteer human subjects. They start by testing a small portion of volunteers made up of 20-80 people. Highly toxic drugs, such as certain formulations used for treating cancer, will only be given to patients already affected by the disease.
The 2nd phase of the experiments will examine the drug dosage amount that people can take and will establish the proper dosage level. A group of between 100 and 300 individuals will take part in a study, which will be conducted in a clinical setting and take up to two years.
Between 1000 and 3000 subjects are needed for phase 3 studies, where drugs are examined on a much bigger scale. Treatment results from the test drug given to disease sufferers will be compared to results from other drugs that are already available. This stage will normally last approximately 2 to 4 years and offers the most practical outcome for the drug’s nature. A control group of people who are only given a placebo pill will be used during phase 3 research studies. It is done to compare the effects of the drug on individuals who suffer the disease but are not treated.
If the drug is found to be safe as well as effective, a new drug application is sent to the FDA for approval and subsequent distribution. Every two years the drug must go through further tests for safety purposes. After the first three phases are completed and the drug is certified, phase 4 starts. Side effects of the drug resulting from long term use along with the general usefulness of the drug are the topics studied in a phase 4 study. It also will examine if various versions of the drug are effective and the way different levels of the dose can change its efficiency.
When a drug is introduced into the market, it is tested repeatedly and made better until its expiration. Up to 20 years can go by between the time a new drug is first envisioned in a lab and when it is marketed to consumers. Medical experiments are a multi-billion dollar business and it costs millions for each separate medicine in the effort to make our health better.
Tags: before permitted, creation, new medications